Suppr超能文献

利多卡因、罗哌卡因和布比卡因在下颌后牙拔除术中控制疼痛的疗效比较。

Comparison of efficacy of lignocaine, ropivacaine, and bupivacaine in pain control during extraction of mandibular posterior teeth.

作者信息

Nazeer Jazib, Kumari Soni, Haidry Nazia, Kulkarni Pranay, Gautam Ashesh, Gupta Preeti

机构信息

Department of Oral Pathology and Microbiology, Patna Dental College and Hospital, Patna, Bihar, India.

Department of Orthodontics and Dentofacial Orthopedics, Hazaribag College of Dental Sciences and Hospital, Demotand, India.

出版信息

Natl J Maxillofac Surg. 2021 May-Aug;12(2):238-243. doi: 10.4103/njms.NJMS_14_20. Epub 2021 Jul 15.

Abstract

BACKGROUND

The management of pain during extraction of mandibular third molars is an important requisite to achieve patient comfort and to obtain desired result in an effective manner. There are various anesthetics that can be used to achieve regional or local anesthetic effect in this regard.

AIM

The aim of this study was to compare the efficacy of 2% lignocaine with 1:80,000 adrenaline, 0.75% ropivacaine and bupivacaine in pain control during extraction of mandibular posterior teeth.

MATERIALS AND METHODS

This prospective, cross-sectional study included 300 study participants indicated for mandibular third molar surgical extractions. The study subjects were categorized into three broad groups - (a) Group I ( = 100): Third molar extractions performed using 2% Lignocaine with 1: 80,000 epinephrine; (b) Group II ( = 100): This group included subjects who underwent extractions of mandibular third molars using 0.75% ropivacaine and (c) Group III ( = 100): This group included patients who underwent extractions of mandibular third molars with bupivacaine. Inclusion criteria were: (a) partially impacted mandibular third molars which were symptomatic; (b) written informed consent. Exclusion criteria were - (a) any systemic diseases and/or undergoing any medication for same; (b) subjects not willing for extraction after clinical and radiographic examination and opinion and (c) subjects undergoing orthodontic therapy. Subject response for pain was recorded using - (a) visual analog scale (VAS) and (b) Verbal Rating scale (VRS). Postoperative pain was assessed using requirement of analgesics after extraction. SPSS version 21.0 was employed as statistical software. Statistical tool used was the Analysis of Variance test which was used for determining statistical significance which was set at a value of lesser than 0.05 (significant).

RESULTS

On analysis of visual analog scale (VAS), it was observed that in Group I (2% Lignocaine with 1:80,000), no pain during the extraction procedure was demonstrated in 30 study participants while minimal or less pain was present in 70 patients, while in Group II (0.75% ropivacaine), 90 patients presented with no pain while ten patients had presented with minimal amount of pain during tooth extraction. While on the other hand, Group III patients whose mandibular third molars were extracted using local anesthesia by injecting bupivacaine, lack of any pain was observed in 69 patients while minimal pain was noted in 31 individuals. While making statistical comparison between three groups, a significant = 0.03 was observed. Also, postoperative pain was noted in 60% of cases who underwent extraction using 2% lignocaine (Group I), 10% patients who had third molar extractions under Bupivacaine anesthesia presented with pain whereas none of the patients (0%), demonstrated the presence of pain following third molar extraction.

CONCLUSION

0.75% Ropivacaine is the most effective local anesthetic agent that can be used for extracting mandibular third molars due to its effective pain control both during and following the procedure when compared to 2% lignocaine and bupivacaine.

摘要

背景

下颌第三磨牙拔除术中的疼痛管理是实现患者舒适并有效获得理想效果的重要前提。在这方面,有多种麻醉剂可用于实现区域或局部麻醉效果。

目的

本研究的目的是比较2%利多卡因与1:80,000肾上腺素、0.75%罗哌卡因和布比卡因在下颌后牙拔除术中控制疼痛的效果。

材料与方法

这项前瞻性横断面研究纳入了300名拟行下颌第三磨牙外科拔除术的研究参与者。研究对象被分为三大组:(a)第一组(n = 100):使用2%利多卡因与1:80,000肾上腺素进行第三磨牙拔除术;(b)第二组(n = 100):该组包括使用0.75%罗哌卡因进行下颌第三磨牙拔除术的受试者;(c)第三组(n = 100):该组包括使用布比卡因进行下颌第三磨牙拔除术的患者。纳入标准为:(a)有症状的部分阻生下颌第三磨牙;(b)书面知情同意书。排除标准为:(a)任何全身性疾病和/或正在接受针对该疾病的任何药物治疗;(b)经临床和影像学检查及评估后不愿意拔牙的受试者;(c)正在接受正畸治疗的受试者。使用以下方法记录受试者的疼痛反应:(a)视觉模拟量表(VAS)和(b)语言评定量表(VRS)。术后疼痛通过拔牙后镇痛药的使用情况进行评估。使用SPSS 21.0版作为统计软件。所使用的统计工具是方差分析检验,用于确定统计学意义,设定P值小于0.05(具有显著性)。

结果

通过对视觉模拟量表(VAS)的分析,观察到在第一组(2%利多卡因与1:80,000)中,30名研究参与者在拔牙过程中未表现出疼痛,70名患者有轻微或较轻疼痛;而在第二组(0.75%罗哌卡因)中,90名患者在拔牙时未表现出疼痛,10名患者有轻微疼痛。另一方面,在第三组中,使用布比卡因局部麻醉拔除下颌第三磨牙的患者中,69名患者未出现任何疼痛,31名患者有轻微疼痛。在对三组进行统计学比较时,观察到显著的P = 0.03。此外,在使用2%利多卡因进行拔牙的病例中,60%出现了术后疼痛;在布比卡因麻醉下拔除第三磨牙的患者中,10%出现了疼痛,而在第三磨牙拔除术后,没有患者(0%)出现疼痛。

结论

与2%利多卡因和布比卡因相比,0.75%罗哌卡因是用于拔除下颌第三磨牙的最有效的局部麻醉剂,因为它在手术过程中和术后都能有效控制疼痛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0d/8386260/31d8ed35f269/NJMS-12-238-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验